| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2011 , Vol 53 , Num 1
FABRICATION AND IN VITRO EVALUATION OF GLIQUIDONE MATRIX TABLETS WITH ABELMOSCHUS ESCULENTUS FRUIT MUCILAGE AND POVIDONE COMBINATION
College of Pharmacy, Sri Krishnadevaraya University, Anantapur, Andhra Pradesh, India
Viewed :
15840
-
Downloaded :
5050
The main objective of the present study was to develop matrix tablets of Gliquidone with Abelmoschus esculentus fruit mucilage and Povidone and to study its functionality as a matrix forming agent for controlled release tablet formulations. Physicochemical properties of dried powdered mucilage of A. esculentus mucilage were studied. Various formulations containing Gliquidone, A. esculentus fruit mucilage and Povidone were prepared. The drug-excipient compatibility studies, physicochemical properties, pre compression and post compression properties were performed and satisfactory results were obtained. These results proved that the dried A. esculentus mucilage and Povidone combination can be used as a matrix forming material for making controlled release matrix tablets.
Keywords :
GLIQUIDONE, ABELMOSCHUS ESCULENTUS, POVIDONE, MATRIX TABLETS, CONTROLLED RELEASE